Premium
Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster
Author(s) -
Aiello Giuseppe,
Sabino Cosimo,
Pernici Davide,
Audano Matteo,
Antonica Francesco,
Gianesello Matteo,
Ballabio Claudio,
Quattrone Alessandro,
Mitro Nico,
Romanel Alessandro,
Soldano Alessia,
Tiberi Luca
Publication year - 2022
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.15252/embr.202255299
Subject(s) - drosophila melanogaster , biology , drosophila (subgenus) , longevity , larva , developmental biology , melanogaster , model organism , genetics , microbiology and biotechnology , evolutionary biology , gene , ecology
Lifespan is determined by complex and tangled mechanisms that are largely unknown. The early postnatal stage has been proposed to play a role in lifespan, but its contribution is still controversial. Here, we show that a short rapamycin treatment during early life can prolong lifespan in Mus musculus and Drosophila melanogaster . Notably, the same treatment at later time points has no effect on lifespan, suggesting that a specific time window is involved in lifespan regulation. We also find that sulfotransferases are upregulated during early rapamycin treatment both in newborn mice and in Drosophila larvae, and transient dST1 overexpression in Drosophila larvae extends lifespan. Our findings unveil a novel link between early‐life treatments and long‐term effects on lifespan.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom